Discover
EDIT
Editas Medicine, Inc.
2.97
37 x 2.96
28 x 2.97
bid
ask
+
0.16
5.61%
01:31 PM
timesize
| Ytd | 44.77% | |
| 1y | 34.90% |
2.83
day range
2.99
1.66
52 week range
4.54
| Open | 2.86 | Prev Close | 2.81 | Low | 2.83 | High | 2.99 | Mkt Cap | 455.01M |
| Vol | 1.08M | Avg Vol | 2.55M | EPS | -0.75 | P/E | -3.95 | Forward P/E | -0.53 |
| Beta | 2.14 | Short Ratio | 6.70 | Inst. Own | 70.94% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-05 | 50-d Avg | 2.90 | 200-d Avg | 2.60 | 1yr Est | 3.67 |
| Income Statement | |||
| Total Revenue | 11.89M | ||
| Revenues (USD) | 11.89M | ||
| Gross Profit | 11.89M | ||
| Operating Expenses | 30.44M | ||
| Research and Development Expense | 20.18M | ||
| Selling, General and Administrative Expense | 11.60M | ||
| Operating Income | -18.55M | ||
| Interest Expense | -307.00K | ||
| Net Income | -18.23M | ||
| Net Income Common Stock | -18.23M | ||
| Net Income Common Stock (USD) | -18.23M | ||
| Consolidated Income | -18.23M | ||
| Earnings per Basic Share | -0.15 | ||
| Earnings per Basic Share (USD) | -0.15 | ||
| Earnings per Diluted Share | -0.15 | ||
| Earning Before Interest & Taxes (EBIT) | -18.54M | ||
| Earning Before Interest & Taxes (USD) | -18.54M | ||
| Weighted Average Shares | 119.29M | ||
| Weighted Average Shares Diluted | 119.29M | ||
| Balance Sheet | |||
| Cash and Equivalents | 181.82M | ||
| Cash and Equivalents (USD) | 181.82M | ||
| Investments | 29.83M | ||
| Investments Current | 29.83M | ||
| Trade and Non-Trade Receivables | 2.73M | ||
| Current Assets | 218.07M | ||
| Property, Plant & Equipment Net | 16.32M | ||
| Total Assets | 237.36M | ||
| Debt Current | 14.01M | ||
| Total Debt | 71.25M | ||
| Current Liabilities | 68.43M | ||
| Debt Non-Current | 57.24M | ||
| Total Liabilities | 132.08M | ||
| Accumulated Retained Earnings (Deficit) | -1.67B | ||
| Accumulated Other Comprehensive Income | -6.00K | ||
| Shareholders Equity | 105.28M | ||
| Shareholders Equity (USD) | 105.28M | ||
| Assets Non-Current | 19.30M | ||
| Total Debt (USD) | 71.25M | ||
| Deferred Revenue | 36.32M | ||
| Liabilities Non-Current | 63.65M | ||
| Trade and Non-Trade Payables | 4.74M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 416.00K | ||
| Net Cash Flow from Financing | 117.54M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 58.17M | ||
| Capital Expenditure | -106.00K | ||
| Issuance (Purchase) of Equity Shares | 117.54M | ||
| Net Cash Flow from Investing | -29.80M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -29.69M | ||
| Net Cash Flow from Operations | -29.57M | ||
| Share Based Compensation | 2.19M | ||